Organisation paid for research Program year 2025 Source: CMS Open Payments

PMG Research, Inc

Neither a doctor nor a teaching hospital

Research payments

$4,041,969

4,916 payments

Through program year 2025, PMG Research, Inc is reported as receiving $4,041,969 in research payments, across 4,916 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$13,765	3
2024	Research	$198,406	80
2023	Research	$688,166	331
2022	Research	$385,558	980
2021	Research	$873,469	1,990
2020	Research	$1,575,246	909
2019	Research	$307,358	623

Breakdown

Who paid Research payments · program years 2019–2025

Novo Nordisk AS $3,364,423 4,658 payments
Gilead Sciences, Inc. $618,459 239 payments
American Regent $48,970 11 payments
Bayer HealthCare Pharmaceuticals Inc. $10,118 8 payments

Studies the money was for Research payments · program years 2019–2025

Ex9536-4388 $923,767 1,081 payments
Nn9932-4954 $456,618 107 payments
Nn9536-4576 $289,881 296 payments
Nn9536-4375 $277,026 84 payments
Ex9924-4473 $276,368 381 payments
Nn9536-4373 $214,688 52 payments
Nn9536-4578 $147,929 842 payments
Nn9536-4374 $121,037 146 payments
Nn9924-4635 $101,871 85 payments
Nn9535-4321 $91,406 278 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.